Page last updated: 2024-08-24

rolofylline and Disease Exacerbation

rolofylline has been researched along with Disease Exacerbation in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	5 (83.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cleland, JGF; Cotter, G; Davison, BA; Dittrich, HC; Edwards, C; Filippatos, G; Givertz, MM; Greenberg, B; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Voors, AA	1
Berezikov, E; Bloomfield, DM; Bruno, N; Cleland, JG; Cotter, G; Davison, B; de Boer, RA; Dittrich, HC; Givertz, MM; Hillege, HL; Metra, M; O'Connor, CM; Ovchinnikova, ES; Pinto, YM; Ponikowski, P; Schmitter, D; Teerlink, JR; ter Maaten, JM; Valente, MA; van der Harst, P; van der Meer, P; van Veldhuisen, DJ; Vegter, EL; Voors, AA	1
Bloomfield, DM; Cleland, JG; Cotter, G; Davison, BA; Dittrich, HC; Edwards, C; Givertz, MM; Massie, BM; Metra, M; Milo, O; O'Connor, CM; Ponikowski, P; Senger, S; Teerlink, JR; Voors, AA	1
Biegus, J; Bloomfield, DM; Cleland, JG; Cotter, G; Davison, BA; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Postmus, D; Teerlink, JR; Valente, MA; Voors, AA	1
Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Givertz, MM; Hanberg, JS; Hillege, HL; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Ter Maaten, JM; Testani, JM; van Veldhuisen, DJ; Voors, AA	1
Bloomfield, DM; Cotter, G; Dittrich, HC; Massie, BM; Metra, M; O'Connor, CM; Weatherley, BD	1

Trials

4 trial(s) available for rolofylline and Disease Exacerbation

Article	Year
Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies. JACC. Heart failure, 2015, Volume: 3, Issue:5 Topics: Acute Disease; Disease Progression; Diuretics; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Male; Prognosis; Relaxin; Treatment Outcome; Xanthines	2015
MicroRNAs relate to early worsening of renal function in patients with acute heart failure. International journal of cardiology, 2016, Jan-15, Volume: 203 Topics: Acute Disease; Aged; Biomarkers; Creatinine; Disease Progression; Diuretics; Double-Blind Method; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gene Expression Regulation; Glomerular Filtration Rate; Heart Failure; Humans; Male; MicroRNAs; Real-Time Polymerase Chain Reaction; Renal Insufficiency; Retrospective Studies; Xanthines	2016
Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure. Circulation. Heart failure, 2016, Volume: 9, Issue:8 Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Chlorides; Disease Progression; Diuretics; Down-Regulation; Drug Resistance; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Risk Factors; Time Factors; Treatment Outcome; Xanthines	2016
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. Journal of cardiac failure, 2008, Volume: 14, Issue:8 Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Cardiovascular Agents; Confidence Intervals; Disease Progression; Diuresis; Dyspnea; Female; Heart Failure; Humans; Male; Pilot Projects; Renal Insufficiency; Risk; Risk Factors; Xanthines	2008

Other Studies

2 other study(ies) available for rolofylline and Disease Exacerbation

Article	Year
Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. European journal of heart failure, 2016, Volume: 18, Issue:8 Topics: Acute Disease; Aged; Comorbidity; Diabetes Mellitus; Disease Progression; Diuretics; Edema; Female; Heart Failure; Hospitalization; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Ischemia; Odds Ratio; Patient Readmission; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency; Severity of Illness Index; Xanthines	2016
Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. European journal of heart failure, 2016, Volume: 18, Issue:7 Topics: Acute Disease; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Disease Progression; Diuretics; Female; Heart Failure; Humans; Liver Function Tests; Male; Middle Aged; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Serum Albumin; Xanthines	2016

Article

Year

Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.

European journal of heart failure, 2016, Volume: 18, Issue:8

Topics: Acute Disease; Aged; Comorbidity; Diabetes Mellitus; Disease Progression; Diuretics; Edema; Female; Heart Failure; Hospitalization; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Ischemia; Odds Ratio; Patient Readmission; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency; Severity of Illness Index; Xanthines

2016

Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.

European journal of heart failure, 2016, Volume: 18, Issue:7

Topics: Acute Disease; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Disease Progression; Diuretics; Female; Heart Failure; Humans; Liver Function Tests; Male; Middle Aged; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Serum Albumin; Xanthines

2016